Litcius/Paper detail

Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain

Xiaomin Ni, Martin Schröder, Vincent Oliéric, M.E. Sharpe, Víctor Hernández‐Olmos, Ewgenij Proschak, Daniel Merk, Stefan Knapp, A. Chaikuad

2021ACS Medicinal Chemistry Letters48 citationsDOIOpen Access PDF

Abstract

The nsP3 macrodomain is a conserved protein interaction module that plays essential regulatory roles in the host immune response by recognizing and removing posttranslational ADP-ribosylation sites during SARS-CoV-2 infection. Thus targeting this protein domain may offer a therapeutic strategy to combat current and future virus pandemics. To assist inhibitor development efforts, we report here a comprehensive set of macrodomain crystal structures complexed with diverse naturally occurring nucleotides, small molecules, and nucleotide analogues including GS-441524 and its phosphorylated analogue, active metabolites of remdesivir. The presented data strengthen our understanding of the SARS-CoV-2 macrodomain structural plasticity and provide chemical starting points for future inhibitor development.

Topics & Concepts

Structural plasticitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)MetaboliteComputational biologySmall moleculeNucleotideBiologyPandemicImmune systemPhosphorylationChemistryVirologyCell biologyMedicineBiochemistryGeneticsGeneNeuroscienceDiseasePathologyInfectious disease (medical specialty)RNA and protein synthesis mechanismsPARP inhibition in cancer therapySARS-CoV-2 and COVID-19 Research